Abstract
Insulin is a major hormone of polypeptides that regulates the metabolism of carbohydrates. Diabetes mellitus, characterized by chronic hyperglycemia, is associated with excessive levels of insulin. As a result, accurate insulin quantification is important for hyperglycemia diagnosis and care. Insulin's main purpose is to keep blood sugar levels in check. Insulin performs its functions by binding to nerve terminals on liver,fat, and striated muscle. In response to an increase in blood glucose levels, insulin facilitates the migration of the endothelial glycosyltransferases type iii (GLUT4) to a cellular membranes, increasing glucose absorption in insulin-sensitive periphery tissues such as fat and muscle. The activation of liver glycogenesis is then aided by insulin.Finally, insulin signals the liver to avoid processing glucose by preventing both glycogenolysis and gluconeogenesis. Where there is a low level of glucose in the blood, glycogens are converted to glucose and released into the bloodstream. The key instruments for detecting insulin have been immunochromatographic techniques. The current research focuses on the different analytical methods for assessing Insulin levels. This study looked at assay methods (AlphaLISA,ELISA,RIA,CLIA, HTRF, and on-chip motilal oswal financial), column chromatography immunoassay (LC-MS/MS andHPLC-UV, MECC,), but also novel science, industrial, and research biosensor assays. ELISA has long been a standard instrument in therapeutic immunoassays because of its high output. On the other hand, advanced computational methods, including such spectroscopy techniques, are incredibly specific but promising instruments that can differentiate between glucose and its analogues. The advantages and disadvantages of the most common methods were also discussed.
Full text article
References
Abellan, R., Ventura, R., Palmi, I., di Carlo, S., di Gio vannandrea, R., Bellver, M., Olive, R., Pascual, J. A., Pacifici, R., Segura, J., Zuccaro, P., Pichini, S. 2009. Evaluation of immunoassays for the measurement of insulin and C-peptide as indirect biomarkers of insulin misuse in sport: Values in selected population of athletes. Journal of Pharmaceutical and Biomedical Analysis, 49(3):793–799.
Arnolds, S., Kuglin, B., Kapitza, C., Heise, T. 2010. How pharmacokinetic and pharmacodynamic principles pave the way for optimal basal insulin therapy in type 2 diabetes. International Journal of Clinical Practice, 64(10):1415–1424.
Baynes, H.W. 2015. Classification, pathophysiology, diagnosis and management of diabetes mellitus. J diabetes metab, 6(5):1–9.
Carslake, H.B., Pinchbeck, G.L., McGowan, C.M. 2017. Evaluation of a Chemilumines cent Immunoassay for Measurement of Equine Insulin. Journal of Veterinary Internal Medicine, 31(2):568–574.
Chaluvaraju, K.C., Niranjan, M.S., Manjuthej, T.R., Zaranappa, T.R., Mane, K. 2012. Review of insulin and its analogues in diabetes mellitus. Journal of Basic and Clinical Pharmacy, 3(2):283.
Chambers, E.E., Fountain, K.J., Smith, N., Ashraf, L., Karalliedde, J., Cowan, D., Legido-Quigley, C. 2014. Multidimensional LC-MS/MS Enables Simultaneous Quantification of Intact Human Insulin and Five Recombinant Analogs in Human Plasma. Analytical Chemistry, 86(1):694–702.
Chen, Z., Caulfield, M.P., McPhaul, M.J., Reitz, R.E., Taylor, S.W., Clarke, N.J. 2013. Quantitative Insulin Analysis Using Liquid Chromatography–Tandem Mass Spectrometry in a High-Throughput Clinical Laboratory. Clinical Chemistry, 59(9):1349–1356.
Darby, S.M., Miller, M.L., Allen, R.O., LeBeau, M. 2001. A Mass Spectrometric Method for Quantitation of Intact Insulin in Blood Samples. Journal of Analytical Toxicology, 25(1):8–14.
Farino, Z.J., Morgenstern, T.J., Vallaghe, J., Gregor, N., Donthamsetti, P., Harris, P.E., Pierre, N., Freyberg, R., Charrier-Savournin, F., Javitch, J.A., Freyberg, Z. 2016. Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence. PLOS ONE, 11(2): e0148684.
Georgiou, G., Ippolito, G.C., Beausang, J., Busse, C.E., Wardemann, H., Quake, S.R. 2014. The promise and challenge of high-throughput sequencing of the antibody repertoire. Nature Biotechnology, 32(2):158–168.
Kalra, S.P., Kalra, P.S. 2004. NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides, 38(4):201–211.
Keating, G.M. 2012. Erratum to Azacitidine: a review of its use in the management of myelodysplastic syndromes/acute myeloid leukaemia. Drugs, 72(11):1578.
Lamalle, C., Servais, A.-C., Radermecker, R.P., Crommen, J., Fillet, M. 2015. Simultaneous determination of insulin and its analogues in pharmaceutical formulations by micellar electrokinetic chromatography. Journal of Pharmaceutical and Biomedical Analysis, 111:344–350.
Manley, S.E., Stratton, I.M., Cull, C.A., Frighi, V., Eeley, E.A., Matthews, D.R., Holman, R.R., Turner, R.C., Neil, H.A.W. 2000. Effects of three months’ diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). Diabetic Medicine, 17(7):518–523.
Ogbera, A.O. 2014. Diabetes mellitus in Nigeria: The past, present and future. World Journal of Diabetes, 5(6):905.
Rafati, A., Zarrabi, A., Abediankenari, S., Aarabi, M., Gill, P. 2018. Sensitive colorimetric assay using insulin G-quadruplex aptamer arrays on DNA nanotubes coupled with magnetic nanoparticles. Royal Society Open Science, 5(3):171835.
Schmudlach, A., Felton, J., Cipolla, C., Sun, L., Kennedy, R.T., Dovichi, N.J. 2016. Sample preparation protocol for bottom-up proteomic analysis of the secretome of the islets of Langerhans. The Analyst, 141(5):1700–1706.
Taylor, S.W., Clarke, N.J., Chen, Z., McPhaul, M.J. 2016. A high-throughput mass spectrometry assay to simultaneously measure intact insulin and C-peptide. Clinica Chimica Acta, 455:202–208.
Wang, F., Surh, J., Kaur, M. 2012. Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review. Diabetes, metabolic syndrome and obesity: targets and therapy, 5:191–204.
Wang, J., Ibáñez, A., Chatrathi, M.P., Escarpa, A. 2001. Electrochemical Enzyme Immunoassays on Microchip Platforms. Analytical Chemistry, 73(21):5323–5327.
Warnken, T., Huber, K., Feige, K. 2016. Comparison of three different methods for the quantification of equine insulin. BMC Veterinary Research, 12(1):1– 10.
Yehezkel, E., Weinstein, D., Simon, M., Sarfstein, R., Laron, Z., Werner, H. 2010. Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin like growth factor-I receptor. Diabetologia, 53(12):2667–2675.
Yilmaz, B., Kadioglu, Y., Capoglu, I. 2012. Determination of Insulin in Humans with Insulin-Dependent Diabetes Mellitus Patients by HPLC with Diode Array Detection. Journal of Chromatographic Science, 50(7):586–590.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.